Chart calendar NicOx SA
Upcoming events on NicOx SA
Past events on NicOx SA
2024-04-22 01:30 am | Q1 2024 Sales and Revenue Release - Q4 2023 Earnings |
2024-04-10 08:30 am | Extraordinary Shareholders Meeting - First Call |
2024-02-28 | American Glaucoma Society Meeting |
2024-01-25 01:30 am | Q4 2023 Earnings Release |
2023-11-02 | American Academy of Ophthalmology Meeting |
2023-10-20 01:30 am | Q3 2023 Sales and Revenue Release |
2023-10-08 | Investor Access Event |
2023-09-12 12:00 am | H.C. Wainwright Global Investment Conference |
2023-07-19 01:30 am | Q2 2023 Sales and Revenue Release |
2023-06-27 | World Glaucoma Congress |
2023-06-21 | Spring Midcap Conference |
2023-06-15 08:00 am | Shareholders Meeting - Second call |
2023-06-04 | BIO International Convention |
2023-06-01 08:00 am | Shareholders Meeting - First call |
2023-05-13 | BioEquity Europe Conference |
2023-04-25 11:45 am | Association for Research in Vision and Ophthalmology Meeting - Poster No: NCX 1728 |
2023-04-25 08:45 am | Association for Research in Vision and Ophthalmology Meeting - Poster No: NCX 470 |
2023-04-22 | Association for Research in Vision and Ophthalmology Meeting |
2023-04-19 01:30 am | Q1 2023 Sales and Revenue Release |
2023-04-03 | Investor Access Conference |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 4,03 4,62 -12.82% | 6,90 8,53 -19.11% | 8,90 9,21 -3.37% | 7,23 7,23 0.1% | 3,27 9,03 -63.76% | 4,20 4,03 4.14% |
EBITDA Million EUR | Released Forecast Spread | -20,4 -17,8 -14.7% | -11,2 -8,70 -28.84% | -5,02 -11,7 57.12% | -16,6 -19,8 16.08% | -22,9 -19,0 -20.44% | 0,00 -16,4 - |
EBIT Million EUR | Released Forecast Spread | -20,7 -16,5 -25.64% | -18,3 -16,5 -10.83% | -6,76 -16,9 60.04% | -46,0 -20,1 -128.56% | -34,0 -33,1 -2.69% | 0,00 -16,5 - |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -18,3 -13,9 -31.35% | -22,8 -15,7 -45.09% | -18,1 -22,1 18.16% | -47,4 -22,5 -110.71% | -30,3 -24,2 -24.93% | 0,00 -14,9 - |
Net income Million EUR | Released Forecast Spread | -18,4 -15,9 -15.62% | -18,9 -11,9 -59.01% | -18,1 -22,4 19.34% | -43,8 -22,9 -90.69% | -27,8 -24,4 -13.97% | 0,00 -15,0 - |
EPS EUR | Released Forecast Spread | -0,62 -0,59 -5.98% | -0,62 -0,38 -65.33% | -0,54 -0,66 18.18% | -1,17 -0,57 -106.47% | -0,63 -0,54 -16.67% | 0,00 -0,30 - |
Announcement Date | 06/03/19 | 06/03/20 | 01/03/21 | 28/04/22 | 20/03/23 | - |
Quarterly results
Fiscal Period | December | 2019 S1 | 2019 S2 | 2020 S1 | 2020 S2 | 2021 Q2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 5,59 | 1,27 1,00 26.5% | 2,40 | 6,60 1,20 450% | 0,72 0,70 3.14% | 1,32 2,10 -37.05% | 2,40 2,48 -3.38% | 3,48 3,50 -0.63% | 0,70 | 0,70 0,75 -6.67% | 1,43 | 0,80 0,75 6.67% | 1,04 1,00 4.1% | 0,90 0,95 -5.26% | 1,10 1,00 10% | 1,20 | 4,30 | 1,50 | 1,60 |
EBIT Million EUR | Released Forecast Spread | -13,0 -12,5 -4.3% | 0,87 -16,2 105.36% | -5,25 | -12,2 -12,0 -1.27% | -4,20 | -6,70 | -6,70 | -6,80 | -3,92 | -4,50 | -4,40 | ||||||||
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -18,2 -13,4 -36.03% | -3,49 -17,2 79.72% | -7,95 | -11,7 -12,8 8.3% | -4,40 | -6,90 | -6,90 | -7,00 | -3,62 | -4,50 | -4,40 | ||||||||
Net income Million EUR | Released Forecast Spread | -18,2 -13,4 -35.6% | -3,49 -17,2 79.7% | -7,95 | -11,7 -12,8 8.49% | -4,40 | -6,90 | -6,90 | -17,0 | -7,00 | -3,62 | -4,50 | -4,40 | |||||||
EPS EUR | Released Forecast Spread | -0,03 | -0,59 -0,40 -47.5% | -0,51 | -0,21 | -0,32 -0,34 5.88% | -0,11 | -0,16 | -0,16 | -0,15 | -0,07 | -0,07 | -0,08 | -0,07 | ||||||
Announcement Date | 26/09/19 | 06/03/20 | 10/09/20 | 01/03/21 | 24/09/21 | 24/09/21 | 28/01/22 | 28/04/22 | - | 16/09/22 | 16/09/22 | 20/12/22 | 20/03/23 | - | - | - | - | - | - |